HCAHCA Healthcare, Inc.
Services-General Medical & Surgical Hospitals, NEC
- Revenue
- $75.6B
- 7.1% YoY
- Operating margin
- —
- EBITDA
- —
- Market cap
- $99.8B
- Employees
- 320,000
- $236K revenue each
- Net debt / EBITDA
- —
- $49.6B net debt
- AI in 10-K
- 6.0
- mentions per 10K words
Takeover score 1 of 13
Fixable underperformance 0 of 7
- TSR below peersNo—3+ of last 5 years
- High CEO pay despite TSRNo—Median CEO pay ≥ $15M while TSR trails
- Earnings not backed by cashNo186% of net incomeCash flow under 80% of net income
- Dilutive SBCNo1% of revenueOver 10% of revenue
- Payouts exceed cash flowNo85% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyNo4% of assetsOver 40% of assets
- Shareholder dissentNo93% lowest supportAny vote under 80% support
Buyer economics 0 of 4
- Low revenue per employeeNo$236K · 54th pctBottom quartile of its SIC industry
- Quiet on AINo6.0 per 10K words · 86th pctBottom quartile of AI mentions in 10-Ks
- Net cashNo—More cash than debt, positive EBITDA
- Buyout-sizedNo$99.8B market capMarket cap $500M–$5B
Catalysts 1 of 2
- Active 13DNo0 filingsActive-intent 13D in 18 months
- Net insider sellingYes−$31M netNet sales over $10M in 12 months
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $58.8B | $60.2B | $65.0B | $70.6B | $75.6B | 7.1% |
| Net income | $7.0B | $5.6B | $5.2B | $5.8B | $6.8B | 18% |
| Operating cash flow | $9.0B | $8.5B | $9.4B | $10.5B | $12.6B | 20% |
| Capex | $3.6B | $4.4B | $4.7B | $4.9B | $4.9B | 1.4% |
| Stock-based comp | $440M | $341M | $262M | $360M | $401M | 11% |
| Buybacks | $8.2B | $7.0B | $3.8B | $6.0B | $10.1B | 67% |
| Dividends | $624M | $653M | $661M | $690M | $679M | 1.6% |
Deal filings
None.
13D filers
| Filed | Filer | Form | Stake | Intent |
|---|---|---|---|---|
| Feb 10, 2026 | Frisco Holding II | SCHEDULE 13D | 65.4% | Passive |
Insider trading
- Open-market buys, 12 mo
- $0 · 0
- Open-market sells, 12 mo
- $31M · 13
- Net
- −$31M
Pay vs performance
No pay-versus-performance disclosure yet.